FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF : an Italian Trial in Medical Oncology (ITMO) studyBAJETTA, E; DI BARTOLOMEO, M; BOCHICCHIO, A. M et al.British journal of cancer. 1998, Vol 77, Num 7, pp 1149-1154, issn 0007-0920Article

Metastatic colorectal cancer: integrating irinotecan into combination and sequential chemotherapyDOUILLARD, J.-Y; SOBRERO, A; CARNAGHI, C et al.Annals of oncology. 2003, Vol 14, pp ii7-ii12, issn 0923-7534, SUP2Conference Paper

5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumorsBAJETTA, E; RIMASSA, L; CARNAGHI, C et al.Cancer. 1998, Vol 83, Num 2, pp 372-378, issn 0008-543XArticle

Irinotecan and raltitrexed: an active combination in advanced colorectal cancerCARNAGHI, C; RIMASSA, L; GARASSINO, I et al.Annals of oncology. 2002, Vol 13, Num 9, pp 1424-1429, issn 0923-7534, 6 p.Article

Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancerBAJETTA, E; BIGANZOLI, L; CARNAGHI, C et al.Cancer. 1998, Vol 83, Num 6, pp 1136-1141, issn 0008-543XArticle

Glutamine supplementation in cancer patients receiving chemotherapy : A double-blind randomized studyBOZZETTI, F; BIGANZOLI, L; GAVAZZI, C et al.Nutrition (Burbank, Los Angeles County, Calif.). 1997, Vol 13, Num 7-8, pp 748-751, issn 0899-9007Conference Paper

EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patientsCAPPUZZO, F; FINOCCHIARO, G; DESTRO, A et al.Annals of oncology. 2008, Vol 19, Num 4, pp 717-723, issn 0923-7534, 7 p.Article

Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsCAPPUZZO, F; VARELLA-GARCIA, M; HOLMES, A. J et al.British journal of cancer. 2008, Vol 99, Num 1, pp 83-89, issn 0007-0920, 7 p.Article

A phase II randomized multicenter trial of gefitinib plus FOLFIRI and FOLFIRI alone in patients with metastatic colorectal cancerSANTORO, A; COMANDONE, A; PRESSIANI, T et al.Annals of oncology. 2008, Vol 19, Num 11, pp 1888-1893, issn 0923-7534, 6 p.Article

Clinical significance of neuroendocrine phenotype in non-small-cell lung cancerCARNAGHI, C; RIMASSA, L; GARASSINO, I et al.Annals of oncology. 2001, Vol 12, pp 119-123, issn 0923-7534, SUP2Conference Paper

Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisPRESSIANI, T; BONI, C; LATINI, L et al.Annals of oncology. 2013, Vol 24, Num 2, pp 406-411, issn 0923-7534, 6 p.Article

Agreement between oncology guidelines and clinical practice in Italy : The 'right' program. A project of the Italian Association of Medical Oncology (AIOM)BARNI, S; VENTURINI, M; BERETTA, G. D et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi179-vi184, SUP6Conference Paper

A dose-finding study of lanreotide (a somatostatin analog) in patients with colorectal carcinomaDI LEO, A; BAJETTA, E; FERRARI, L et al.Cancer. 1996, Vol 78, Num 1, pp 35-42, issn 0008-543XArticle

Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors : A study by the Italian Trials in Medical Oncology GroupDI BARTOLOMEO, M; BAJETTA, E; BUZZONI, R et al.Cancer. 1996, Vol 77, Num 2, pp 402-408, issn 0008-543XArticle

Doxifluridine as palliative treatment in advanced gastric and pancreatic cancer patientsDI BARTOLOMEO, M; BAJETTA, E; SOMMA, L et al.Oncology. 1996, Vol 53, Num 1, pp 54-57, issn 0030-2414Article

Phase II study of vinorelbine in patients with pretreated advanced ovarian Cancer : Activity in platinum-resistant diseaseBAJETTA, E; DI LEO, A; BUZZONI, R et al.Journal of clinical oncology. 1996, Vol 14, Num 9, pp 2546-2551, issn 0732-183XArticle

The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumoursBAJETTA, E; CARNAGHI, C; FERRARI, L et al.Digestion. 1996, Vol 57, pp 72-76, issn 0012-2823, SUP1Conference Paper

A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O) GroupDI BARTOLOMEO, M; BAJETTA, E; BOCHICCHIO, A. M et al.Annals of oncology. 1995, Vol 6, Num 1, pp 77-79, issn 0923-7534Article